Goldman Sachs’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117M | Sell |
4,996,787
-698,588
| -12% | -$15.2M | 0.01% | 941 |
|
|
2025
Q4 | $120M | Buy |
5,695,375
+208,941
| +4% | +$3.65M | 0.01% | 881 |
|
|
2025
Q3 | $84.4M | Sell |
5,486,434
-310,761
| -5% | -$4.07M | 0.01% | 1049 |
|
|
2025
Q2 | $54.3M | Buy |
5,797,195
+1,875,654
| +48% | +$20.6M | 0.01% | 1281 |
|
|
2025
Q1 | $48.2M | Sell |
3,921,541
-2,028,996
| -34% | -$28.6M | 0.01% | 1256 |
|
|
2024
Q4 | $78.7M | Buy |
5,950,537
+4,338,485
| +269% | +$74.3M | 0.01% | 951 |
|
|
2024
Q3 | $31M | Buy |
1,612,052
+168,040
| +12% | +$3.47M | 0.01% | 1663 |
|
|
2024
Q2 | $29.6M | Buy |
1,444,012
+133,939
| +10% | +$2.8M | 0.01% | 1544 |
|
|
2024
Q1 | $31.2M | Buy |
1,310,073
+59,125
| +5% | +$1.32M | 0.01% | 1495 |
|
|
2023
Q4 | $27M | Sell |
1,250,948
-16,800
| -1% | -$258K | 0.01% | 1636 |
|
|
2023
Q3 | $18.4M | Buy |
1,267,748
+521,363
| +70% | +$9.86M | ﹤0.01% | 1880 |
|
|
2023
Q2 | $15.6M | Buy |
746,385
+255,612
| +52% | +$5.32M | ﹤0.01% | 2055 |
|
|
2023
Q1 | $10.4M | Buy |
490,773
+52,530
| +12% | +$1.31M | ﹤0.01% | 2382 |
|
|
2022
Q4 | $11.2M | Sell |
438,243
-129,838
| -23% | -$3.03M | ﹤0.01% | 2480 |
|
|
2022
Q3 | $13.7M | Buy |
568,081
+21,842
| +4% | +$490K | ﹤0.01% | 2211 |
|
|
2022
Q2 | $10.5M | Buy |
546,239
+137,976
| +34% | +$2.3M | ﹤0.01% | 2466 |
|
|
2022
Q1 | $7.09M | Buy |
408,263
+44,602
| +12% | +$751K | ﹤0.01% | 3019 |
|
|
2021
Q4 | $7.96M | Buy |
363,661
+43,553
| +14% | +$805K | ﹤0.01% | 2971 |
|
|
2021
Q3 | $6.12M | Sell |
320,108
-756,660
| -70% | -$12.6M | ﹤0.01% | 3185 |
|
|
2021
Q2 | $18.5M | Buy |
1,076,768
+513,163
| +91% | +$9.4M | ﹤0.01% | 2116 |
|
|
2021
Q1 | $12.6M | Buy |
563,605
+9,171
| +2% | +$207K | ﹤0.01% | 2354 |
|
|
2020
Q4 | $12.3M | Buy |
554,434
+302,464
| +120% | +$6.27M | ﹤0.01% | 2278 |
|
|
2020
Q3 | $3.72M | Sell |
251,970
-185,492
| -42% | -$2.83M | ﹤0.01% | 3125 |
|
|
2020
Q2 | $6.48M | Buy |
437,462
+421,773
| +2,688% | +$6.42M | ﹤0.01% | 2605 |
|
|
2020
Q1 | $172K | Sell |
15,689
-46,353
| -75% | -$435K | ﹤0.01% | 4757 |
|
|
2019
Q4 | $545K | Buy |
62,042
+39,305
| +173% | +$289K | ﹤0.01% | 4460 |
|
|
2019
Q3 | $170K | Sell |
22,737
-3,231
| -12% | -$29.4K | ﹤0.01% | 4860 |
|
|
2019
Q2 | $241K | Buy |
25,968
+11,594
| +81% | +$84.5K | ﹤0.01% | 4703 |
|
|
2019
Q1 | $75K | Sell |
14,374
-38,968
| -73% | -$222K | ﹤0.01% | 4964 |
|
|
2018
Q4 | $237K | Sell |
53,342
-13,057
| -20% | -$71.6K | ﹤0.01% | 4747 |
|
|
2018
Q3 | $537K | Sell |
66,399
-8,716
| -12% | -$62.1K | ﹤0.01% | 4386 |
|
|
2018
Q2 | $527K | Buy |
75,115
+58,706
| +358% | +$576K | ﹤0.01% | 4475 |
|
|
2018
Q1 | $234K | Sell |
16,409
-42,338
| -72% | -$449K | ﹤0.01% | 4912 |
|
|
2017
Q4 | $515K | Buy |
+58,747
| New | +$581K | ﹤0.01% | 4813 |
|
|
2016
Q2 | – | Sell |
-26,500
| Closed | -$353K | – | 7239 |
|
|
2016
Q1 | $353K | Buy |
+26,500
| New | +$333K | ﹤0.01% | 5101 |
|
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM
